Skip to main content

Heidi J. Wehring, PharmD

Academic Title:

Adjunct Associate Professor

Primary Appointment:



Maryland Psychiatric Research Center/Tawes Building

Phone (Primary):




Education and Training

Univeristy of Iowa, BS, Psychology, 1995

University of Iowa, PharmD, Pharmacy, 2000

University of Maryland, Psychiatric Pharmacy Residency, 2001

University of Maryland School of Medicine, Postdoctoral Psychiatry Fellowship, 2011


Dr. Wehring is an Assistant Professor of Psychiatry, Maryland Psychiatric Research Center.  Dr. Wehring is a board-certified psychiatric pharmacist and has dedicated her career to specializing in clinical research and treatment of adults and children with serious mental illness.  Her main areas of interest include treatment-resistant schizophrenia, co-occurring mental illness and substance use disorders, and psychopharmacology in pediatric populations.

Research/Clinical Keywords

Schizophrenia, Tobacco Craving, Smoking Cessation, Pediatric Psychopharmacology

Highlighted Publications

Wehring HJ*, Elsobky T*, McEvoy JP, Vyas G, Richardson CM, McMahon RP, DiPaula BA, Liu F, Sullivan K, Buchanan RW, Feldman S, McMahon E, Kelly DL.  Adjunctive minocycline in clozapine-treated patients with schizophrenia: analyzing the effects of minocycline on clozapine plasma levels.  Psychiatric Quarterly, in press 2017.

Wehring HJ, Heishman SJ, McMahon RP, Liu F, Feldman S, Raley H, Weiner E, Kelly DL.  Antipsychotic treatment and tobacco craving in people with schizophrenia.  J Dual Diagn 2017 Feb; [Epub ahead of print]. PMID: 28166471.

Wehring HJ, Perez G, Dixon L, Kelly DL.  Women and Addiction:  Compounding the picture with mental illness.  Current Women’s Health Reviews, 2013.

Wehring HJ, Liu F, McMahon RP, Mackowick KM, Love RC, Dixon L, Kelly DL. Clinical Characteristics of Heavy and Light Smokers with Schizophrenia. Schizophrenia Research; 138(2-3):285-9. PMID: 22578720

Awards and Affiliations

2012                                H. McKee Jarboe Award for Mental Health Research, UMSOM

2014                                American College of Neuropsychopharmacology, Travel Awardee

Grants and Contracts

4/2013 – 3/2018               

Heidi Wehring, PI, 85% funded effort

NIDA K23 DA034034

“Tobacco Craving in Smokers with Schizophrenia”.